Allison Morton

3.4k total citations
33 papers, 832 citations indexed

About

Allison Morton is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Allison Morton has authored 33 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 20 papers in Cardiology and Cardiovascular Medicine and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Allison Morton's work include Coronary Interventions and Diagnostics (17 papers), Acute Myocardial Infarction Research (9 papers) and Cardiac Imaging and Diagnostics (6 papers). Allison Morton is often cited by papers focused on Coronary Interventions and Diagnostics (17 papers), Acute Myocardial Infarction Research (9 papers) and Cardiac Imaging and Diagnostics (6 papers). Allison Morton collaborates with scholars based in United Kingdom, Austria and Australia. Allison Morton's co-authors include Julian Gunn, David C. Crossman, Paul Morris, Patricia V. Lawford, D. Rodney Hose, Robert F. Storey, Robin Condliffe, David G. Kiely, Javaid Iqbal and Catherine Hill and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Allison Morton

31 papers receiving 814 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allison Morton United Kingdom 13 503 487 259 257 60 33 832
Marcello Dominici Italy 12 769 1.5× 597 1.2× 332 1.3× 216 0.8× 36 0.6× 30 1.1k
Gaku Nakazawa Japan 14 627 1.2× 402 0.8× 292 1.1× 352 1.4× 38 0.6× 44 824
Vikas Thondapu United States 16 498 1.0× 309 0.6× 190 0.7× 273 1.1× 28 0.5× 43 633
Simon Corbett United Kingdom 16 459 0.9× 564 1.2× 204 0.8× 525 2.0× 55 0.9× 37 1.1k
J. Eduardo Sousa Brazil 14 859 1.7× 619 1.3× 331 1.3× 323 1.3× 90 1.5× 62 1.1k
Victoria Martín‐Yuste Spain 15 300 0.6× 415 0.9× 110 0.4× 212 0.8× 39 0.7× 63 684
Jorge Saucedo United States 12 580 1.2× 471 1.0× 133 0.5× 239 0.9× 33 0.6× 36 788
Daniel B. Fram United States 16 439 0.9× 394 0.8× 146 0.6× 137 0.5× 72 1.2× 42 711
Umberto Barbero Italy 15 352 0.7× 395 0.8× 119 0.5× 191 0.7× 48 0.8× 49 693
Erion Xhepa Germany 15 843 1.7× 732 1.5× 353 1.4× 371 1.4× 157 2.6× 124 1.3k

Countries citing papers authored by Allison Morton

Since Specialization
Citations

This map shows the geographic impact of Allison Morton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison Morton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison Morton more than expected).

Fields of papers citing papers by Allison Morton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison Morton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison Morton. The network helps show where Allison Morton may publish in the future.

Co-authorship network of co-authors of Allison Morton

This figure shows the co-authorship network connecting the top 25 collaborators of Allison Morton. A scholar is included among the top collaborators of Allison Morton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison Morton. Allison Morton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, Mark R., Allison Morton, Rashed Hossain, et al.. (2016). Morphine delays the onset of action of prasugrel in patients with prior history of ST-elevation myocardial infarction. Thrombosis and Haemostasis. 116(7). 96–102. 48 indexed citations
2.
McCullagh, Brian, Christine Costello, Lili Li, et al.. (2015). Elevated Plasma CXCL12α Is Associated with a Poorer Prognosis in Pulmonary Arterial Hypertension. PLoS ONE. 10(4). e0123709–e0123709. 26 indexed citations
3.
Parviz, Yasir, Sethumadhavan Vijayan, Javaid Iqbal, et al.. (2015). Percutaneous brachial artery access for coronary artery procedures: Feasible and safe in the current era. Cardiovascular revascularization medicine. 16(8). 447–449. 18 indexed citations
5.
Kaudewitz, Dorothee, Regent Lee, Peter Willeit, et al.. (2013). Abstract 18427: Impact of Medication on Quantification of Plasma MicroRNAs in Patients With Cardiovascular Disease. Circulation. 128(suppl_22).
6.
Morris, Paul, et al.. (2013). Virtual Fractional Flow Reserve From Coronary Angiography: Modeling the Significance of Coronary Lesions. JACC: Cardiovascular Interventions. 6(2). 149–157. 205 indexed citations
7.
Malkin, Christopher J., et al.. (2013). Residual SYNTAX score after PCI for triple vessel coronary artery disease: quantifying the adverse effect of incomplete revascularisation. EuroIntervention. 8(11). 1286–1295. 51 indexed citations
8.
Clark, Matthew, Nigel Hoggard, Allison Morton, et al.. (2013). Metal-on-Metal Hip Prostheses and Systemic Health: A Cross-Sectional Association Study 8 Years after Implantation. PLoS ONE. 8(6). e66186–e66186. 50 indexed citations
9.
Swift, Andrew J., Smitha Rajaram, Judith Hurdman, et al.. (2013). Noninvasive Estimation of PA Pressure, Flow, and Resistance With CMR Imaging. JACC. Cardiovascular imaging. 6(10). 1036–1047. 107 indexed citations
10.
Hossain, Rashed, Allison Morton, Rosemary Ecob, et al.. (2013). Evolving pattern of platelet P2Y12inhibition in patients with acute coronary syndromes. Platelets. 25(6). 416–422. 10 indexed citations
11.
Daly, Rebecca, Sonal Mehra, Rosemary Ecob, et al.. (2013). Hirudin anticoagulation allows more rapid determination of P2Y12 inhibition by the VerifyNow P2Y12 assay. Thrombosis and Haemostasis. 109(3). 550–555. 7 indexed citations
12.
13.
Condliffe, Robin, Josephine Pickworth, Sara J. Walker, et al.. (2012). Serum Osteoprotegerin is Increased and Predicts Survival in Idiopathic Pulmonary Arterial Hypertension. Pulmonary Circulation. 2(1). 21–27. 20 indexed citations
15.
Gunn, Julian, et al.. (2011). Novel use of a pericardium‐covered stent graft to treat bulky coronary artery thrombus. Catheterization and Cardiovascular Interventions. 80(1). 59–64. 6 indexed citations
16.
Kelly, Darren J. & Allison Morton. (2011). Activation of Hypoxia-Inducible Factor by Di-Methyl Oxalyl Glycine (DMOG) Increases Neovascularization within Ischaemic Myocardium in a Porcine Coronary Artery Occlusion Model. Journal of Clinical & Experimental Cardiology. 2(8). 2 indexed citations
18.
Morton, Allison, et al.. (2006). Simultaneous kissing stent technique to treat left main stem bifurcation disease. Catheterization and Cardiovascular Interventions. 69(2). 209–215. 18 indexed citations
19.
Morton, Allison, David C. Crossman, & Julian Gunn. (2004). The influence of physical stent parameters upon restenosis. Pathologie Biologie. 52(4). 196–205. 90 indexed citations
20.
Morton, Allison, Thomas Papadopoulos, Robert Bowes, et al.. (2003). Real world small vessel coronary artery stenting: an analysis. UEA Digital Repository (University of East Anglia). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026